The following in an excerpt from a New York Times article this morning announcing that a Doctor in New York City has been diagnosed with Ebola, the first case in NYC.
A doctor in New York […]
Open Enrollment for Medicare Advantage and Medicare prescription drug coverage (commonly known as Part C and Part D) begins October 15th and ends December 7th. During that time, Medicare participants can:
We hate having to share stories like this from today’s New York Times, Extendicare Agrees to Pay $38 Million in Fines for Inadequate Nursing Home Care, but it is so important for people to understand why regular and thorough investigation of extending living facilities is crucial. There are a host […]
Our Founder Sarah O’Leary pokes fun at insurance company telephone hold times and delivers helpful tips for your next call with the insurance company in this Huffington Post article:
Exhale Health is committed to sharing useful information to individuals and families about health insurance and healthcare.
Women’s Health featured an article written by CEO Sarah O’Leary. It shares concrete suggestions to help families better navigate their care. Please feel free to share it with your loved ones. Be smart, […]
How long are you willing to wait on hold before you simply hang up? Most people lose their patience after several minutes. The more determined may stay on for an hour or longer. Insurance company telephone hold times have increased dramatically over the past year, with some consumers reporting hold […]
The Health Insurance Portability and Accountability Act, better known as HIPAA, provides a variety of protections to ensure patients’ privacy.
“The HIPAA Privacy Rule provides federal protections for individually identifiable health information held by covered entities and their business associates and gives patients an array of rights with respect to that […]
In today’s New York Times, Elisabeth Rosenthal reported on the increase in pricing of some generic drugs.(http://www.nytimes.com/2014/07/09/health/some-generic-drug-prices-are-soaring.html?emc=edit_tnt_20140709&nlid=65544527&tntemail0=y). It is patently unfair to significantly raise drug pricing simply for corporate profit, especially on drugs primarily sold to senior citizens, many of whom may be on a fixed income. The […]